when does semaglutide go off patent Ozempic's Patent Protection Starts to Expire in 2026. What Next?

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely? On March 20, 2026, the patent protecting Novo Nordisk's semaglutide expired in India. Within 24 hours, the market transformed. Leading pharmaceutical giants,

29.83

★★★★☆4.8 (126)

Last week's expiry of the patent for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions

29.26

★★★★★4.9 (98)

Obesity Drugs Set To Take Off, Patent Expires In 2 Days

20.20

★★★★★5.0 (157)

Semaglutide (Ozempic) Market: Navigating The Patent Cliff And Strategic Implications

29.51

★★★★★4.7 (84)

Everyone talked about Ozempic. Few looked at what its patent expiry actually means for Indian pharma investors. Semaglutide is now off-patent in India. Ten Indian companies have already launched. Per Nomura, this

20.77

★★★★★4.9 (203)

Semaglutide (Ozempic) Market: Navigating The Patent Cliff And Strategic Implications

28.56

★★★★★5.0 (176)

Ozempic Patent Ends On March 20 And A Generic Deluge Is Coming Forcing Prices To Fall

27.34

★★★★★4.8 (132)